RT Journal Article
SR Electronic
T1 Role of NADPH-Cytochrome P450 Reductase and Cytochrome-<em>b</em><sub>5</sub>/NADH-<em>b</em><sub>5</sub> Reductase in Variability of CYP3A Activity in Human Liver Microsomes
JF Drug Metabolism and Disposition
JO Drug Metab Dispos
FD American Society for Pharmacology and Experimental Therapeutics
SP 90
OP 96
DO 10.1124/dmd.108.023424
VO 37
IS 1
A1 Lu Gan
A1 Lisa L. von Moltke
A1 Lauren A. Trepanier
A1 Jerold S. Harmatz
A1 David J. Greenblatt
A1 Michael H. Court
YR 2009
UL http://dmd.aspetjournals.org/content/37/1/90.abstract
AB NADPH-cytochrome P450 reductase (CPR) and cytochrome-b5 (b5) together with NADH-b5 reductase (b5R) play important roles in cytochrome P450 3A-mediated drug metabolism via electron transfer. However, it is not clear whether variability in expression of these accessory proteins contributes to the known interindividual variability in CYP3A activity. CPR and b5 were measured in human liver microsomes (HLMs) by spectrophotometry and immunoblotting. HLMs from elderly (≥46 years) male donors (n = 11) averaged 27% (P = 0.034) and 41% (P = 0.011) lower CPR levels than young (≤45 years) male donors (n = 21) for spectrophotometric and immunoblot values, respectively. Similarly, HLMs from elderly male donors averaged 43% (P = 0.034) and 47% (P = 0.011) lower b5 levels than young male donors for spectrophotometric and immunoblot values, respectively. α-Lipoic acid and 6-propyl-2-thiouracil were evaluated for selectivity of inhibition of CPR and b5R activities, respectively, using recombinant enzymes and HLMs, as well as for effects on CYP3A-mediated triazolam hydroxylation in HLMs with either NADH or β-NADPH. The results indicate that both compounds are relatively nonselective inhibitors of CPR and b5R activities. Finally, we used multivariate regression analysis and showed that variability in CPR or b5 expression between HLMs does not contribute significantly to variability in CYP3A-mediated midazolam hydroxylation. Consequently, while aging is associated with decreased CPR and b5 expression in human livers, this effect does not contribute to CYP3A variability. The American Society for Pharmacology and Experimental Therapeutics